深圳康泰生物制品股份有限公司 focuses on the research, production, and sales of human vaccines. It has established itself as a significant player in the innovative biopharmaceutical industry with various vaccine technologies and products.

深圳康泰生物制品股份有限公司

深圳康泰生物制品股份有限公司 | 118 followers on LinkedIn. 创造更好的疫苗，造福人类健康。
Create better vaccines to benefit human health. | Founded in 1992, BioKangtai champions innovation through key scientific research and technology projects, boosting our R&amp;D and industrial capabilities. Follow us for the latest updates! Create better vaccines to benefit human health.

深圳康泰生物制品股份有限公司 - 安环总监

Chen Shuigen

深圳康泰生物制品股份有限公司 - 地区销售主管

陈淑芳

BD manager, BioKangtai

Xue Li

深圳康泰生物制品股份有限公司 （股票代码:300601）

任广

We are pleased to announce that our brand new website is about to go live! 🎉 Get ready for an exciting experience filled with product development and industry news. 🌐 Established in 1992, Shenzhen Kangtai Biological Products Co., Ltd. is a company dedicated to the research, development and production of biological products to protect human health. Please continue to follow updates and become one of the first explorers!

Shenzhen Kangtai Biological Products Co., Ltd. researches, develops, produces, and sells various types of human vaccines in China. The company's products include cell-free whitebait b-type haemophilus influenzae combined vaccine, SARS-COV-2 vaccine, recombinant hepatitis B vaccine, 23-valent pneumococcal polysaccharide vaccine, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccine, haemophilus influenzae type b conjugate vaccine, measles and rubella combined with live attenuated vaccine, 13-valent pneumococcal conjugate vaccine, rabies vaccine, inactivated poliomyelitis vaccine, and HIB conjugate vaccine. It has an agreement between YTB and Yong Tai Berhad in relation to the development and commercialization of Covid-19 inactivated vaccine in Malaysia. Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is based in Shenzhen, China.

Shenzhen Kangtai Biological Products Co., Ltd.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 17, 2024 8:43 PM	a3a43abe
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 17, 2024 8:43 PM	65735a90
crunchbase trigger	general	Nov 17, 2024 8:43 PM	7e6665ec
crunchbase profile	general	Nov 17, 2024 9:05 PM	6e9710ab
li profile	general	Nov 17, 2024 8:43 PM	f50971e9
translate crunchbase fundingrounds	general
peers	general	Nov 17, 2024 8:43 PM	5e3060c2
news basic	general	Nov 17, 2024 8:43 PM	c8019ba3
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

3006

COM:BIOKANGTAI

深圳康泰生物制品股份有限公司

Last Close

19.05

22/11 07:04

Market Cap

16.99B

Beta: -

Volume Today

15.14M

Avg: -